Reviewing the therapeutic role of budesonide in Crohn's disease.

Gastroenterol Hepatol

Servei d'Aparell Digestiu, Hospital Germans Trias i Pujol, Badalona, Barcelona, España; Centro de Investigaciones Biomédicas en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, España. Electronic address:

Published: March 2019

Oral budesonide is a glucocorticoid of primarily local action. In the field of digestive diseases, it is used mainly in inflammatory bowel disease, but also in other indications. This review addresses the pharmacology, pharmacodynamics and therapeutic use of budesonide. Its approved indications are reviewed, as well as other clinical scenarios in which it could play a role, in order to facilitate its use and improve the accuracy of its prescription.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gastrohep.2018.05.013DOI Listing

Publication Analysis

Top Keywords

reviewing therapeutic
4
therapeutic role
4
role budesonide
4
budesonide crohn's
4
crohn's disease
4
disease oral
4
oral budesonide
4
budesonide glucocorticoid
4
glucocorticoid local
4
local action
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!